MDT — Medtronic plc. stock price and chart

MDT

Medtronic plc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.2% · US Stock Market 0.1% · Russell 3000 0.1%

$90.96-0.72%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

80.090.0100.0110.0120.0130.0050.0M$90.96

2026-09-11

Price$90.96

MA20$83.75

MA50$90.66

Vol42.9M

What would $1,000 invested in MDT be worth today? →

MDT returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $90.96
Change YTD: -3.67%
Market cap: 116.4B2016-09 119.4B2026-09 116.4B-2.5% over the window
Enterprise value: 137.5B
Shares outstanding: 1.3B2016-07 1.4B2026-07 1.3B-7.4% over the window
52W low: $73.31
52W high: $106.33
From 52W high: -14.46%
From 52W low: +24.08%
52W range: 53%
Beta: 0.55

Volume

Rel volume: 0.72×
30D volume: 7.5M
30D $ vol: 678.3M

Fundamentals

Sales (ttm): 37.5B2016-07 28.7B2026-07 37.5B+30.7% over the window
Sales/share: $29.352016-07 $20.792026-07 $29.35+41.2% over the window
EPS (ttm): $4.062016-07 $2.572026-07 $4.06+58.1% over the window
FCF (ttm): 6.1B2016-07 4.8B2026-07 6.1B+27.8% over the window
FCF/share: $4.792016-07 $3.472026-07 $4.79+38.0% over the window
Book value/share: $39.272016-07 $36.782026-07 $39.27+6.8% over the window
Net margin: 13.93%2016-07 12.7%2026-07 13.9%+9.7% over the window
ROE: 10.41%2016-07 7.2%2026-07 10.4%+45.1% over the window
ROA: 5.61%2016-07 3.7%2026-07 5.6%+51.5% over the window
Debt / equity: 0.51×2016-07 0.592026-07 0.51-14.0% over the window
Current ratio: 2.072016-07 2.982026-07 2.07-30.5% over the window

Growth (CAGR, ttm) · 10Y

Sales: +9.61%2025-07-25 → 2026-07-3134.2B → 37.5B (+9.8% total)+5.94%2023-07-28 → 2026-07-3131.6B → 37.5B (+19.0% total)+3.51%2021-07-30 → 2026-07-3131.6B → 37.5B (+18.8% total)+2.71%2016-07-29 → 2026-07-3128.7B → 37.5B (+30.7% total)
Net income: +12.05%2025-07-25 → 2026-07-314.7B → 5.2B (+12.3% total)+13.02%2023-07-28 → 2026-07-313.6B → 5.2B (+44.5% total)+6.14%2021-07-30 → 2026-07-313.9B → 5.2B (+34.8% total)+3.67%2016-07-29 → 2026-07-313.6B → 5.2B (+43.4% total)
FCF: +15.37%2025-07-25 → 2026-07-315.3B → 6.1B (+15.6% total)+11.29%2023-07-28 → 2026-07-314.4B → 6.1B (+38.0% total)+0.93%2021-07-30 → 2026-07-315.9B → 6.1B (+4.7% total)+2.48%2016-07-29 → 2026-07-314.8B → 6.1B (+27.8% total)
Shares: -0.27%2025-07-25 → 2026-07-311.3B → 1.3B (-0.3% total)-1.30%2023-07-28 → 2026-07-311.3B → 1.3B (-3.9% total)-1.01%2021-07-30 → 2026-07-311.3B → 1.3B (-5.0% total)-0.77%2016-07-29 → 2026-07-311.4B → 1.3B (-7.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +12.00%2025-07-25 → 2026-07-31$3.62 → $4.06 (+12.2% total)+14.32%2023-07-28 → 2026-07-31$2.72 → $4.06 (+49.6% total)+7.24%2021-07-30 → 2026-07-31$2.86 → $4.06 (+41.9% total)+4.68%2016-07-29 → 2026-07-31$2.57 → $4.06 (+58.1% total)
Sales/share: +9.91%2025-07-25 → 2026-07-31$26.66 → $29.35 (+10.1% total)+7.33%2023-07-28 → 2026-07-31$23.72 → $29.35 (+23.7% total)+4.56%2021-07-30 → 2026-07-31$23.48 → $29.35 (+25.0% total)+3.51%2016-07-29 → 2026-07-31$20.79 → $29.35 (+41.2% total)
FCF/share: +15.69%2025-07-25 → 2026-07-31$4.13 → $4.79 (+16.0% total)+12.76%2023-07-28 → 2026-07-31$3.34 → $4.79 (+43.5% total)+1.96%2021-07-30 → 2026-07-31$4.35 → $4.79 (+10.2% total)+3.27%2016-07-29 → 2026-07-31$3.47 → $4.79 (+38.0% total)
Book value/share: +5.09%2025-07-25 → 2026-07-31$37.34 → $39.27 (+5.2% total)+0.69%2023-07-28 → 2026-07-31$38.46 → $39.27 (+2.1% total)+0.52%2021-07-30 → 2026-07-31$38.26 → $39.27 (+2.6% total)+0.66%2016-07-29 → 2026-07-31$36.78 → $39.27 (+6.8% total)
Dividend/share: +1.40%2025-07-25 → 2026-07-31$2.81 → $2.85 (+1.4% total)+1.44%2023-07-28 → 2026-07-31$2.73 → $2.85 (+4.4% total)+3.76%2021-07-30 → 2026-07-31$2.37 → $2.85 (+20.3% total)+6.14%2016-07-29 → 2026-07-31$1.57 → $2.85 (+81.5% total)
Price: -3.49%2025-09-11 → 2026-09-11$94.25 → $90.96 (-3.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.77%2023-09-11 → 2026-09-11$81.40 → $90.96 (+11.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.05%2021-09-10 → 2026-09-11$131.14 → $90.96 (-30.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.70%2016-09-09 → 2026-09-11$84.87 → $90.96 (+7.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -0.35%2025-09-11 → 2026-09-11$91.28 → $90.96 (-0.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.24%2023-09-11 → 2026-09-11$73.76 → $90.96 (+23.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.10%2021-09-10 → 2026-09-11$112.13 → $90.96 (-18.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.41%2016-09-09 → 2026-09-11$65.04 → $90.96 (+39.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 22.4×2016-09 32.732026-09 22.25-32.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.1×2016-09 22.122026-09 17.15-22.5% over the window
Fwd P/E: 14.7×
P/S (ttm)Market cap ÷ TTM revenue.: 3.1×2016-09 4.162026-09 3.10-25.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.3×2016-09 2.352026-09 2.32-1.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 19.0×2016-09 24.872026-09 18.98-23.7% over the window
EV/EBITDA (fy): 14.1×
EV/Sales (ttm): 3.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 5.27%2016-07 4.0%2026-07 6.1%+50.6% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 3.13%
Dividend/share (fwd): $2.85
Buyback yield (realized, 1y)1 − shares_at(2026-07-31) ÷ shares_at(2025-07-25) = 1 − 1.28B ÷ 1.28B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 0.27%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.27%) + dividends paid over that year ($3.6B) ÷ market_cap_at(2025-07-25) ($119.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.33%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($738M) ÷ today's market cap ($116.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.63%2016-07 3.2%2026-07 0.7%-77.4% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $738M + TTM dividends $3.6B) ÷ today's market cap ($116.4B). Same caveat as the cash buyback yield.: 3.77%2016-07 5.1%2026-07 4.3%-14.4% over the window

Vs own 10Y history

P/E: 6th
P/OI: 6th
P/S: 5th
P/B: 45th
P/FCF: 3rd

Bar = where today’s multiple sits in MDT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.72%

-2.30%

+0.22%

+14.25%

YTD

-3.67%

+1.73%

-21.04%

Financial statements

Open full MDT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Medtronic plc. (MDT) trades at $90.96 with a live price and an interactive chart covering 51+ years of daily price history, plus key valuation metrics. ChartRow also publishes MDT’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MDT financial statements →

MDT — Medtronic plc. price, chart and key statistics